**Research on Ketamine for Treating Sickle Cell Pain in Kids and Young Adults**
*Ketamine* is a medicine that can help with pain. This study checks if a small amount of ketamine is safe and works well for pain in children and young adults (ages 5-20) with *sickle cell disease* (a blood condition causing pain due to blocked blood flow, known as vaso-occlusive pain events or VOE). Patients will get either regular pain medicine like morphine or the same medicine with a low dose of ketamine.
**Key Points:**
- The study involves one additional dose of ketamine along with standard pain treatment.
- Participants need to speak English or Spanish. Consent from a guardian is required, with the child's agreement if possible.
- Those with certain health issues or pregnant individuals cannot join the study.
This study will help determine if adding ketamine to regular pain treatments can better relieve sickle cell-related pain. Participation means contributing to research that could improve therapies for sickle cell disease.
**HTML tags for web page formatting:**
html
Research on Ketamine for Treating Sickle Cell Pain in Kids and Young Adults
Ketamine is a medicine that can help with pain. This study checks if a small amount of ketamine is safe and works well for pain in children and young adults (ages 5-20) with sickle cell disease (a blood condition causing pain due to blocked blood flow, known as vaso-occlusive pain events or VOE). Patients will get either regular pain medicine like morphine or the same medicine with a low dose of ketamine.
- The study involves one additional dose of ketamine along with standard pain treatment.
- Participants need to speak English or Spanish. Consent from a guardian is required, with the child's agreement if possible.
- Those with certain health issues or pregnant individuals cannot join the study.
This study will help determine if adding ketamine to regular pain treatments can better relieve sickle cell-related pain. Participation means contributing to research that could improve therapies for sickle cell disease.
How understandable was the trial content above?
Hard to understand
Easy to understand